🔎 Trials Near Me

Home › Amyotrophic Lateral Sclerosis › Maryland

Amyotrophic Lateral Sclerosis clinical trials in Maryland

16 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in Maryland.

Cities in Maryland

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

  • National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Oct 1, 2026 · NCT07204977

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  • Johns Hopkins University, Baltimore
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07322003

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Sep 17, 2026 · NCT03225144

Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis

  • The Johns Hopkins Hospital, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07823101

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Sunstone Therapies, PC, Rockville
  • Sheppard Pratt, Towson
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

  • Johns Hopkins Medicine, Baltimore
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07521930

ASSESS ALL ALS Study

  • John Hopkins University, Baltimore
  • Nih/Ninds, Bethseda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06578195

PREVENT ALL ALS Study

  • John Hopkins University, Baltimore
  • Nih/Ninds, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06581861

Investigation on the Cortical Communication (CortiCom) System

  • Johns Hopkins Medicine, Baltimore
Recruiting
Ages 22 to 70 · All sexes · Updated Aug 21, 2026 · NCT03567213

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

  • Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06656702

Study of COYA 302 for the Treatment of ALS

  • Johns Hopkins, Baltimore
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Aug 6, 2026 · NCT07161999

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

  • Johns Hopkins University, Baltimore
  • NIH, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04363684

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

  • TidalHealth Peninsula Regional, Inc., Salisbury
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT07491484

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

  • Pharmaron, Inc., Baltimore
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Mar 5, 2026 · NCT07221240

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

  • Johns Hopkins Medicine Brain Science Institute, Baltimore
RecruitingPhase 3
Ages 18 to 81 · All sexes · Updated Sep 12, 2025 · NCT03127267

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.